Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 3.52%36.33M | 923.41%31.86M | -90.68%1.81M | -78.86%883K | -78.89%1.78M | -21.70%35.09M | 3.11M | 19.36M | 4.18M | 8.44M |
| Net profit before non-cash adjustment | 35.88%37.68M | 124.64%15.33M | 29.27%9.1M | -6.93%8.16M | -0.16%5.1M | -15.36%27.73M | --6.82M | --7.04M | --8.76M | --5.11M |
| Total adjustment of non-cash items | 73.51%9.88M | 41.40%2.62M | 43.78%2M | 206.47%2.56M | 67.22%2.7M | -18.93%5.69M | --1.85M | --1.39M | --835K | --1.61M |
| -Depreciation and amortization | 93.43%7.47M | 54.95%1.92M | 105.88%1.82M | 103.47%1.88M | 126.71%1.86M | 3.19%3.86M | --1.24M | --884K | --922K | --820K |
| -Reversal of impairment losses recognized in profit and loss | -184.51%-544.02K | -154.36%-114.02K | -363.35%-740K | -75.82%37K | --273K | 28,664.92%643.76K | --209.76K | --281K | --153K | --0 |
| -Disposal profit | ---12.63K | --375 | --0 | --0 | ---13K | --0 | --0 | --0 | ---- | ---- |
| -Other non-cash items | 149.72%2.96M | 101.02%818.26K | 307.08%920K | 369.17%646K | -26.95%580K | -63.78%1.19M | --407.05K | --226K | ---240K | --794K |
| Changes in working capital | -773.75%-11.23M | 349.92%13.91M | -185.02%-9.29M | -81.38%-9.83M | -449.77%-6.02M | -66.84%1.67M | ---5.56M | --10.93M | ---5.42M | --1.72M |
| -Change in receivables | 123.91%2.6M | 175.92%13.2M | -175.68%-7.29M | -2,219.63%-17.17M | 454.51%13.85M | -223.05%-10.86M | ---17.39M | --9.63M | --810K | ---3.91M |
| -Change in inventory | -418.74%-25.26M | -219.52%-2.1M | -347.35%-4.57M | -32.31%-9.37M | -565.99%-9.22M | -74.31%-4.87M | --1.75M | --1.85M | ---7.08M | ---1.39M |
| -Change in payables | -34.31%11.43M | -72.22%2.8M | 571.96%2.56M | 1,856.79%16.71M | -251.75%-10.64M | 1,830.91%17.4M | --10.07M | ---542K | --854K | --7.01M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 46.23%-2.8M | -255.98%-1.1M | 56.85%-655K | 49.82%-568K | 78.86%-477K | 32.42%-5.22M | -310.38K | -1.52M | -1.13M | -2.26M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 12.20%33.52M | 997.33%30.75M | -93.56%1.15M | -89.66%315K | -78.90%1.31M | -19.46%29.88M | --2.8M | --17.84M | --3.05M | --6.19M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 72.05%-12.8M | 81.01%-2.68M | 84.53%-2.7M | 89.52%-1.33M | -306.14%-6.08M | -348.04%-45.79M | ---14.09M | ---17.46M | ---12.73M | ---1.5M |
| Net intangibles purchase and sale | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Net business purchase and sale | 109.91%20K | ---- | ---- | ---- | --0 | ---201.84K | ---- | ---- | ---- | ---- |
| Net investment product transactions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --61.66M |
| Interest received (cash flow from investment activities) | -21.76%1.71M | -15.24%443.34K | -38.76%384K | -47.38%442K | 121.39%445K | 133.02%2.19M | --523.03K | --627K | --840K | --201K |
| Net changes in other investments | 6.94%5.8M | -1.83%1.85M | -102.79%-104K | ---641K | --4.69M | 212.96%5.42M | --1.89M | --3.73M | ---- | ---- |
| Investing cash flow | 86.28%-5.27M | 96.98%-358.92K | 81.52%-2.42M | 97.92%-1.53M | -101.58%-952K | -408.50%-38.38M | ---11.88M | ---13.1M | ---73.75M | --60.36M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 229.67%28.52M | -82.78%843.42K | -24.33%6.25M | 203.05%14.54M | 132.70%6.88M | -184.09%-22M | --4.9M | --8.26M | ---14.11M | ---21.05M |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | --61.66M | --0 | --0 | ---- | ---- |
| Increase or decrease of lease financing | -113.68%-1.27M | -11.78%-332K | -50.45%-337K | -498.25%-341K | -1,721.43%-255K | -181.19%-592.01K | ---297.01K | ---224K | ---57K | ---14K |
| Issuance fees | --0 | --0 | --0 | --0 | --0 | ---1.85M | ---181 | --0 | ---- | ---- |
| Cash dividends paid | 45.84%-7.04M | --0 | ---- | ---- | ---- | -32.91%-12.99M | ---1.84M | ---3.98M | ---- | ---- |
| Interest paid (cash flow from financing activities) | -38.66%-4.68M | -36.23%-1.27M | -52.87%-1.3M | -81.33%-1.09M | -3.02%-1.03M | 19.90%-3.38M | ---930.08K | ---853K | ---600K | ---995K |
| Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---60.15M |
| Financing cash flow | -25.50%15.53M | -141.16%-755.64K | -175.60%-2.43M | -86.62%13.11M | 106.82%5.6M | 195.01%20.85M | --1.84M | --3.21M | --98.01M | ---82.21M |
| Net cash flow | ||||||||||
| Beginning cash position | 28.85%55.17M | 11.07%69.33M | 34.07%73.02M | 125.06%61.13M | 28.85%55.17M | 21.59%42.82M | --62.42M | --54.47M | --27.16M | --42.82M |
| Current changes in cash | 254.50%43.79M | 509.20%29.64M | -146.52%-3.7M | -56.44%11.9M | 138.04%5.96M | 62.49%12.35M | ---7.24M | --7.95M | --27.31M | ---15.66M |
| End cash Position | 79.37%98.96M | 79.37%98.96M | 11.07%69.33M | 34.07%73.02M | 125.06%61.13M | 28.85%55.17M | --55.17M | --62.42M | --54.47M | --27.16M |
| Free cash flow | 230.28%20.73M | 348.88%28.1M | -506.28%-1.55M | 89.48%-1.02M | -202.39%-4.8M | -159.19%-15.91M | ---11.29M | --382K | ---9.69M | --4.69M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.